RELIEF THERAPEUTICS Ownership
| 0QKQ Stock | 2.23 0.06 2.76% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
RELIEF |
RELIEF Stock Ownership Analysis
About 23.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 0.01. RELIEF THERAPEUTICS had not issued any dividends in recent years. The entity had 0.0025:1 split on the 5th of May 2023. For more info on RELIEF THERAPEUTICS Holding please contact the company at 41 44 723 59 59 or go to https://www.relieftherapeutics.com.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for RELIEF Stock Analysis
When running RELIEF THERAPEUTICS's price analysis, check to measure RELIEF THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RELIEF THERAPEUTICS is operating at the current time. Most of RELIEF THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of RELIEF THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RELIEF THERAPEUTICS's price. Additionally, you may evaluate how the addition of RELIEF THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.